Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical Lymphoma Myeloma and Leukemia, 2022
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments

Fernandez N., Perumal D., Rahman A. et al.

OncologyPathophysiologyPatient Stratification

Molecular Oncology, 2022
Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome

Viktorsson K., Hååg P., Shah C. et al.

Olink Target 96OncologyPatient StratificationPlasmaEV Lysate

International Immunopharmacology, 2022
Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease

Mi J., Liu Z., Pei S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Clinical Cancer Research, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Diorio C., Shraim R., Myers R. et al.

Olink Explore 3072/384OncologyImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

The Lancet Digital Health, 2022
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study

Byeon S., Madugundu A., Garapati K. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Nature Communications, 2022
Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections

Fan Q., Shi J., Yang Y. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Cell Systems, 2022
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity

Ambikan A., Yang H., Krishnan S. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Osteoarthritis and Cartilage Open, 2022
Technical performance of a proximity extension assay inflammation biomarker panel with synovial fluid

Struglics A., Larsson S., Lohmander L. et al.

Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationSerumSynovial Fluid

Osteoarthritis and Cartilage, 2022
The alarmins high mobility group box protein 1 and S100A8/A9 display different inflammatory profiles after acute knee injury

Aulin C., Larsson S., Vogl T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySynovial Fluid

Scientific Reports, 2022
People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells

van Eekeren L., Matzaraki V., Zhang Z. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

PLOS Computational Biology, 2022
ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients

Prasad B., McGeough C., Eakin A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

eBioMedicine, 2022
A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes

Achenbach P., Hippich M., Zapardiel-Gonzalo J. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

Acta Neuropathologica Communications, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Jiang R., Smailovic U., Haytural H. et al.

Olink Target 96 MouseNeurologyPathophysiologyCSF

Cardiovascular Diabetology, 2022
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project

Korduner J., Holm H., Jujic A. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

European Journal of Pharmacology, 2022
Novel purine analogues regulate IL-1β release via inhibition of JAK activity in human aortic smooth muscle cells

Paramel G., Lindkvist M., Idosa B. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

Clinical Nutrition, 2022
Proteomics of the phase angle: Results from the population-based KORA S4 study

Huemer M., Petrera A., Hauck S. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

New Biotechnology, 2022
Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Abu Sabaa A., Shen Q., Lennmyr E. et al.

Olink Target 96OncologyPathophysiologyPatient StratificationPlasma

Cell Reports Medicine, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Feyaerts D., Hédou J., Gillard J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPatient StratificationPlasma

The Lancet Rheumatology, 2022
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study

Clark K., Csomor E., Campochiaro C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasmaInterstitial Fluid (skin blisters)

Clinical Infectious Diseases, 2022
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity

Morrocchi E., Pighi C., Pascucci G. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

1945 publications